WeVote
Log In

Bill

Bill

HB 962

NURSES: Provides relative to reconstitution of medications for intravenous therapy

2026 Regular Session Introduced by Dustin Miller

Louisiana HB 962 authorizes nurses to independently reconstitute IV medications, expanding nursing scope of practice in clinical settings.

Effective date: 08/01/2026.
0
WeVote Research Nonpartisan
Bill Summary · HB 962

Legislative bill overview

HB 962 allows nurses in Louisiana to reconstitute medications for intravenous (IV) therapy under specified conditions. Reconstitution is the process of preparing medications from powder or concentrate form by adding solvents. The bill expands nursing scope of practice to include this clinical task, which was previously restricted or required physician oversight in certain contexts.

Why is this important

IV medication reconstitution is a routine clinical function in hospitals and healthcare settings. Expanding nursing authority to perform this task independently could improve workflow efficiency, reduce delays in medication administration, and potentially lower healthcare costs. However, it also involves questions about patient safety, supervision requirements, and the appropriate boundaries of nursing practice.

Potential points of contention

  • Patient safety and competency standards: Opponents may argue that insufficient safeguards or training requirements could lead to medication errors, while supporters contend nurses are adequately trained for this task
  • Scope of practice boundaries: Questions about whether this represents appropriate professional autonomy or an encroachment into clinical judgment traditionally reserved for pharmacists or physicians
  • Implementation details: The bill's amendments (passed 10-0) may address supervision requirements, specific medications included, or facility types—details that significantly affect practical impact but aren't publicly detailed here

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.